Pharmaids [PHARMAID] vs Aarti Drugs [AARTIDRUGS] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Pharmaids wins in 3 metrics, Aarti Drugs wins in 15 metrics, with 0 ties. Aarti Drugs appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricPharmaidsAarti DrugsBetter
P/E Ratio (TTM)2,023.3322.81Aarti Drugs
Price-to-Book Ratio3.713.14Aarti Drugs
Debt-to-Equity Ratio70.8144.92Aarti Drugs
PEG Ratio23.660.36Aarti Drugs
EV/EBITDA-17.3616.76Pharmaids
Profit Margin (TTM)-61.01%7.80%Aarti Drugs
Operating Margin (TTM)-90.28%10.11%Aarti Drugs
EBITDA Margin (TTM)N/A10.11%N/A
Return on Equity-19.58%12.28%Aarti Drugs
Return on Assets (TTM)-8.99%6.53%Aarti Drugs
Free Cash Flow (TTM)$-264.72M$674.20MAarti Drugs
Dividend YieldN/A0.22%N/A
1-Year Return42.56%-14.34%Pharmaids
Price-to-Sales Ratio (TTM)10.231.77Aarti Drugs
Enterprise Value$2.51B$49.56BAarti Drugs
EV/Revenue Ratio11.752.05Aarti Drugs
Gross Profit Margin (TTM)47.39%36.77%Pharmaids
Revenue per Share (TTM)$6$265Aarti Drugs
Earnings per Share (Diluted)$-3.70$20.65Aarti Drugs
Beta (Stock Volatility)0.380.21Aarti Drugs
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends

Pharmaids vs Aarti Drugs Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Pharmaids-0.43%-0.58%-7.46%-8.45%-12.03%-16.22%
Aarti Drugs2.56%-4.13%-10.00%1.76%27.10%6.05%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Pharmaids42.56%369.70%1,702.33%1,893.57%1,477.61%167.24%
Aarti Drugs-14.34%10.27%-34.08%237.25%2,680.94%2,426.41%

Performance & Financial Health Analysis: Pharmaids vs Aarti Drugs

MetricPHARMAIDAARTIDRUGS
Market Information
Market Cap i₹2.19B₹42.99B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i6,939149,023
90 Day Avg. Volume i9,637593,839
Last Close₹62.00₹483.05
52 Week Range₹31.90 - ₹87.46₹312.00 - ₹635.00
% from 52W High-29.11%-23.93%
All-Time High₹87.46 (Nov 11, 2024)₹1,026.95 (Oct 05, 2020)
% from All-Time High-29.11%-52.96%
Growth Metrics
Quarterly Revenue Growth0.43%0.06%
Quarterly Earnings Growth0.43%0.62%
Financial Health
Profit Margin (TTM) i-0.61%0.08%
Operating Margin (TTM) i-0.90%0.10%
Return on Equity (TTM) i-0.20%0.12%
Debt to Equity (MRQ) i70.8144.92
Cash & Liquidity
Book Value per Share (MRQ)₹16.72₹149.84
Cash per Share (MRQ)₹0.61₹2.48
Operating Cash Flow (TTM) i₹-278,094,000₹2.83B
Levered Free Cash Flow (TTM) i₹-107,766,000₹1.68B
Dividends
Last 12-Month Dividend Yield iN/A0.22%
Last 12-Month Dividend iN/A₹1.00

Valuation & Enterprise Metrics Analysis: Pharmaids vs Aarti Drugs

MetricPHARMAIDAARTIDRUGS
Price Ratios
P/E Ratio (TTM) i2,023.3322.81
Forward P/E iN/A14.86
PEG Ratio i23.660.36
Price to Sales (TTM) i10.231.77
Price to Book (MRQ) i3.713.14
Market Capitalization
Market Capitalization i₹2.19B₹42.99B
Enterprise Value i₹2.51B₹49.56B
Enterprise Value Metrics
Enterprise to Revenue i11.752.05
Enterprise to EBITDA i-17.3616.76
Risk & Other Metrics
Beta i0.380.21
Book Value per Share (MRQ) i₹16.72₹149.84

Financial Statements Comparison: Pharmaids vs Aarti Drugs

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)PHARMAIDAARTIDRUGS
Revenue/Sales i₹66.64M₹6.77B
Cost of Goods Sold i₹35.06M₹4.37B
Gross Profit i₹31.58M₹2.40B
Research & Development iN/AN/A
Operating Income (EBIT) i₹-60.16M₹784.50M
EBITDA i₹-53.69M₹951.90M
Pre-Tax Income i₹-71.71M₹711.50M
Income Tax i₹-18.56M₹83.80M
Net Income (Profit) i₹-53.15M₹627.70M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)PHARMAIDAARTIDRUGS
Cash & Equivalents i₹21.45M₹45.80M
Total Current Assets i₹223.07M₹13.38B
Total Current Liabilities i₹287.15M₹8.37B
Long-Term Debt i₹331.19M₹2.86B
Total Shareholders Equity i₹550.42M₹13.69B
Retained Earnings iN/AN/A
Property, Plant & Equipment i₹446.50M₹8.59B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)PHARMAIDAARTIDRUGS
Operating Cash Flow i₹-1.10MN/A
Capital Expenditures i₹0N/A
Free Cash Flow i₹2.39MN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricPHARMAIDAARTIDRUGS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i6,939149,023
Average Daily Volume (90 Day) i9,637593,839
Shares Outstanding i35.27M91.27M
Float Shares i5.46M35.46M
% Held by Insiders i0.93%0.61%
% Held by Institutions i0.00%0.11%

Dividend Analysis & Yield Comparison: Pharmaids vs Aarti Drugs

MetricPHARMAIDAARTIDRUGS
Last 12-Month Dividend iN/A₹1.00
Last 12-Month Dividend Yield iN/A0.22%
3-Year Avg Annual Dividend iN/A₹1.00
3-Year Avg Dividend Yield iN/A0.23%
3-Year Total Dividends iN/A₹3.00
Ex-Dividend DateN/AFeb 04, 2025